| Chronic Obstructive Pulmonary Disease |
1 |
1 |
| Lung |
0 |
0.99 |
| Inhalers |
0 |
0.48 |
| Chronic Bronchitis |
0 |
0.34 |
| Asthma |
0 |
0.26 |
| Bronchitis |
0 |
0.24 |
| COVID-19 |
0 |
0.24 |
| Prism |
0 |
0.24 |
| Smoking |
0 |
0.24 |
| Toxicology |
0 |
0.21 |
| Tobacco Cessation |
0 |
0.19 |
| Otolaryngology |
0 |
0.18 |
| Adherence |
0 |
0.16 |
| Cancer |
0 |
0.16 |
| Cough |
0 |
0.16 |
| Pulmonary Function Test |
0 |
0.16 |
| Pulmonary Rehabilitation |
0 |
0.16 |
| Physical Medicine and Rehabilitation (PMR) |
0 |
0.15 |
| Care and Maintenance of Vision |
0 |
0.13 |
| Gastroesophageal Reflux Disease |
0 |
0.12 |
| Inhaled Corticosteroid |
0 |
0.11 |
| Healthcare and Medical Technology |
0 |
0.09 |
| Lung Cancer |
0 |
0.09 |
| Airway |
0 |
0.08 |
| Blood |
0 |
0.08 |
| Bronchodilator |
0 |
0.08 |
| Cardiovascular disease |
0 |
0.08 |
| Clinical Research |
0 |
0.08 |
| Corticosteroids |
0 |
0.08 |
| CT Scan |
0 |
0.08 |
| Dyspnea |
0 |
0.08 |
| Emphysema |
0 |
0.08 |
| Eosinophils |
0 |
0.08 |
| Hospital |
0 |
0.08 |
| Immunization |
0 |
0.08 |
| Pollutant |
0 |
0.08 |
| Polypharmacy |
0 |
0.08 |
| Preventive Screening |
0 |
0.08 |
| Prognosis |
0 |
0.08 |
| Tachycardia |
0 |
0.08 |
| Texas |
0 |
0.08 |
| Arrhythmia |
0 |
0.04 |
| Cardiovascular Risk Management |
0 |
0.04 |
| Osteoporosis |
0 |
0.04 |
| Telehealth and Telemedicine |
0 |
0.04 |